Contract

Front-End Developer

Multiple Teams

Posted on 7/15/2025

Lynx Analytics

Lynx Analytics

51-200 employees

Graph analytics and predictive AI solutions

No salary listed

San Francisco, CA, USA

Remote

Category
Software Engineering (1)
Required Skills
React.js
Web Development
Requirements
  • Industry experience shipping products written in ReactJS
  • Ability to quickly prototype new features
  • Ability to integrate mock-ups into working applications
  • Creative talent to bring data science results to life in beautiful and business-friendly visualization
Responsibilities
  • Work with the Data Science Team to develop applications to visualize data and graphs the best possible way
  • Develop wireframes and mock-ups and translate them into actual production interface
  • Liaise with the Backend Team to integrate certain API endpoints
  • Deliver the web applications within the required timeframe and in accordance with defined requirements
  • Collaborate with other teams if required

Lynx Analytics provides software and consulting services that use graph-based artificial intelligence to help businesses analyze complex relationships within large datasets. The technology works by using Apache Spark to process data in real-time, allowing users to visualize patterns and predict outcomes for tasks like fraud detection and customer retention. Unlike competitors that focus on standard data tables, this company specializes in graph theory to map how different data points connect to one another across entire networks. The company's goal is to help organizations in sectors like banking and telecommunications optimize their commercial strategies by uncovering hidden insights within their existing data.

Company Size

51-200

Company Stage

Early VC

Total Funding

$10M

Headquarters

Singapore, Singapore

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • LynxKite 2000:MM scales on Nebius AI Cloud for Graph Neural Networks in healthcare modeling.
  • Biophytis partnership advances AI for obesity and sarcopenia therapies since July 2025.
  • Lumen deploys decision-support agents with citations for pharma strategic planning.

What critics are saying

  • NVIDIA cuGraph commoditizes LynxKite, enabling pharma in-house workflows within 6-12 months.
  • Open-source LynxKite GitHub lets competitors fork GCNs, eroding differentiation in 3-6 months.
  • Databricks GraphStorm captures AstraZeneca deals, outperforming Lumen in 12-24 months.

What makes Lynx Analytics unique

  • LynxKite 2000:MM integrates NVIDIA cuGraph and BioNeMo for GPU-optimized graph AI in drug discovery.
  • Lumen Agentic AI framework powers IlluminAI at AstraZeneca for oncology forecast analytics.
  • Graph RAG combines Graph AI with LLMs for precise life sciences customer segmentation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

5%

2 year growth

1%
PR Newswire Asia
Jan 14th, 2026
Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences

Lynx Analytics introduces Lumen, an Agentic AI framework to improve decision-making in life sciences. LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ - Lynx Analytics today announced Lumen, a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from complex scientific and commercial information. Built specifically for life sciences workflows, Lumen enables companies to deploy AI agents across a wide range of real-world use cases - from rapidly distilling lengthy clinical or market research documents, to generating dynamic HCP personas and personalized engagement strategies, to powering natural-language analytics that explain drivers behind forecast shifts or market performance. The framework brings accumulated best practices from multiple Agentic AI deployments across global pharma companies. One of the first real-world applications built on Lumen is IlluminAI - a customized decision-support solution developed in collaboration with the International Oncology team at AstraZeneca. "The introduction of the IlluminAI assistant at AstraZeneca has streamlined how we approach brand launch planning. Our teams can ask natural-language questions about forecast drivers and receive insights grounded in patient forecast models and revenue data. IlluminAI is now embedded in planning cycles across International Markets. We look forward to continuing our partnership with Lynx Analytics to further develop IlluminAI." said Christos Georgiou, Oncology Launch & Business Excellence Director, International Markets at AstraZeneca. Ankit Agrawal, Director of Client Engagement at Lynx Analytics, added: "Lumen is the foundation for Lynx's next generation of Agentic AI in pharma, already deployed across priority commercial and medical use cases. At AstraZeneca, IlluminAI puts this into practice for the International Oncology team, where agents connect patient forecast models and revenue data to pinpoint the key drivers and assumptions behind each forecast, explained in simple, easy-to-understand language" Lumen enables decision-support agents such as campaign-planning copilots that forecast ROI and generate targeted content; patient-support agents that deliver compliant, 24/7 medical information; and clinical-trial intelligence agents that surface relevant insights and help teams monitor study challenges in real time. All insights include linked citations for transparency, giving teams audit-ready evidence behind each recommendation. Lumen is now available to pharmaceutical and life sciences organizations seeking to elevate strategic planning, accelerate analysis, and deploy responsible AI at scale. About Lynx Analytics Lynx Analytics is a global AI and data-science company specializing in life sciences applications, graph analytics, and Agentic AI systems. The company partners with leading pharmaceutical organizations to transform complex data into strategic advantage.

Biophytis
Jul 15th, 2025
JULY 15, 2025

Biophytis SA, a pioneering force in the development of transformative therapies for obesity, sarcopenia, and longevity, today announced a strategic partnership with Lynx Analytics, a pioneer in artificial intelligence solutions for life sciences.

Money Compass
Mar 19th, 2025
Lynx Analytics Unveils LynxKite 2000:MM - The Next Generation of GPU-Optimized Graph AI

Lynx Analytics unveils LynxKite 2000:MM - The next generation of gpu-optimized Graph AI.

Lynx Analytics
Feb 27th, 2023
Lynx Analytics named as one of Singapore’s 100 fastest growing companies

Lynx Analytics, a Singapore-based AI & analytics company, has been named one of the country & fastest-growing companies by Straits Times, a leading newspaper in Singapore.

INACTIVE